{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:07:45Z","timestamp":1791950865007,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T00:00:00Z","timestamp":1532131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00228-018-2526-1","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T17:57:28Z","timestamp":1532195848000},"page":"1449-1459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp."],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7135-4410","authenticated-orcid":false,"given":"Pier Giorgio","family":"Cojutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Lugano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Della Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,21]]},"reference":[{"issue":"4","key":"2526_CR1","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.1111\/ctr.12129","volume":"27","author":"F Saliba","year":"2013","unstructured":"Saliba F, Delvart V, Ichai P, Kassis N, Botterel F, Mihaila L et al (2013) Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clin Transpl 27(4):E454\u2013E461","journal-title":"Clin Transpl"},{"issue":"2","key":"2526_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jiac.2015.11.005","volume":"22","author":"M Nagao","year":"2016","unstructured":"Nagao M, Fujimoto Y, Yamamoto M, Matsumura Y, Kaido T, Takakura S, Uemoto S, Ichiyama S (2016) Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis. J Infect Chemother 22(2):84\u201389","journal-title":"J Infect Chemother"},{"issue":"4","key":"2526_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/MOT.0000000000000431","volume":"22","author":"R Hogen","year":"2017","unstructured":"Hogen R, Dhanireddy KK (2017) Invasive fungal infections following liver transplantation. Curr Opin Organ Transplant 22(4):356\u2013363","journal-title":"Curr Opin Organ Transplant"},{"issue":"6","key":"2526_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/tid.12613","volume":"18","author":"DR Andes","year":"2016","unstructured":"Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, Hadley S, Herwaldt L, Kauffman C, Lyon GM, Morrison V, Patterson T, Perl T, Walker R, Hess T, Chiller T, Pappas PG, The TRANSNET Investigators (2016) The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the transplant-associated infection surveillance network (TRANSNET). Transpl Infect Dis 18(6):921\u2013931","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"2526_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000673","volume":"3","author":"M Bassetti","year":"2017","unstructured":"Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, de Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C (2017) Invasive Candida infections in liver transplant recipients: clinical features and risk factors for mortality. Transplant Direct 3(5):e156","journal-title":"Transplant Direct"},{"issue":"12","key":"2526_CR6","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1111\/ajt.12925","volume":"14","author":"JD Evans","year":"2014","unstructured":"Evans JD, Morris PJ, Knight SR (2014) Antifungal prophylaxis in liver transplantation: a systematic review and network meta-analysis. Am J Transplant 14(12):2765\u20132776","journal-title":"Am J Transplant"},{"key":"2526_CR7","doi-asserted-by":"crossref","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016) Clinical practice guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1\u2013e50","DOI":"10.1093\/cid\/civ1194"},{"issue":"Suppl 7","key":"2526_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Fl\u00f6rl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19\u201337","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2526_CR9","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/AAC.00163-06","volume":"50","author":"F Sabatelli","year":"2006","unstructured":"Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM (2006) In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 50(6):2009\u20132015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2526_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/157488407779422311","volume":"2","author":"R Bellmann","year":"2007","unstructured":"Bellmann R (2007) Clinical pharmacokinetics of systemically administered antimycotics. Curr Clin Pharmacol 2(1):37\u201358","journal-title":"Curr Clin Pharmacol"},{"issue":"4","key":"2526_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/lt.24391","volume":"22","author":"J Fortun","year":"2016","unstructured":"Fortun J, Muriel A, Martin-Davila P, Montejo M, Len O, Torre-Cisneros J et al (2016) Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: a propensity score analysis. Liver Transpl 22(4):427\u2013435","journal-title":"Liver Transpl"},{"issue":"suppl_1","key":"2526_CR12","doi-asserted-by":"publisher","first-page":"i51","DOI":"10.1093\/jac\/dkx449","volume":"73","author":"M Giannella","year":"2018","unstructured":"Giannella M, Husain S, Saliba F, Viale P (2018) Use of echinocandin prophylaxis in solid organ transplantation. J Antimicrob Chemother 73(suppl_1):i51\u2013ii9","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2526_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s15010-013-0558-0","volume":"42","author":"L Scudeller","year":"2014","unstructured":"Scudeller L, Viscoli C, Menichetti F, del Bono V, Cristini F, Tascini C, Bassetti M, Viale P, ITALIC Group (2014) An Italian consensus for invasive candidiasis management (ITALIC). Infection 42(2):263\u2013279","journal-title":"Infection"},{"issue":"Suppl 1","key":"2526_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/11315540-000000000-00000","volume":"69","author":"C Viscoli","year":"2009","unstructured":"Viscoli C (2009) Antifungal prophylaxis and pre-emptive therapy. Drugs 69(Suppl 1):75\u201378","journal-title":"Drugs"},{"issue":"1","key":"2526_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1128\/AAC.00474-06","volume":"51","author":"MP Pai","year":"2007","unstructured":"Pai MP, Turpin RS, Garey KW (2007) Association of fluconazole area under the concentration-time curve\/MIC and dose\/MIC ratios with mortality in nonneutropenic patients with candidemia. Antimicrob Agents Chemother 51(1):35\u201339","journal-title":"Antimicrob Agents Chemother"},{"issue":"9\u201310","key":"2526_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s002280000216","volume":"56","author":"E Muhl","year":"2000","unstructured":"Muhl E, Martens T, Iven H, Rob P, Bruch HP (2000) Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole. Eur J Clin Pharmacol 56(9\u201310):671\u2013678","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"2526_CR17","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1128\/AAC.00296-07","volume":"51","author":"JL Rodriguez-Tudela","year":"2007","unstructured":"Rodriguez-Tudela JL, Almirante B, Rodriguez-Pardo D, Laguna F, Donnelly JP, Mouton JW, Pahissa A, Cuenca-Estrella M (2007) Correlation of the MIC and dose\/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. Antimicrob Agents Chemother 51(10):3599\u20133604","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2526_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31\u201341","journal-title":"Nephron"},{"issue":"5","key":"2526_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1053\/j.ajkd.2012.08.001","volume":"60","author":"M Flamant","year":"2012","unstructured":"Flamant M, Haymann JP, Vidal-Petiot E, Letavernier E, Clerici C, Boffa JJ, Vrtovsnik F (2012) GFR estimation using the Cockcroft-Gault, MDRD study, and CKD-EPI equations in the elderly. Am J Kidney Dis 60(5):847\u2013849","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2526_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00007691-199208000-00008","volume":"14","author":"K Inagaki","year":"1992","unstructured":"Inagaki K, Takagi J, Lor E, Okamoto MP, Gill MA (1992) Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography. Ther Drug Monit 14(4):306\u2013311","journal-title":"Ther Drug Monit"},{"issue":"4","key":"2526_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","volume":"34","author":"MN Neely","year":"2012","unstructured":"Neely MN, van Guilder MG, Yamada WM, Schumitzky A, Jelliffe RW (2012) Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. Ther Drug Monit 34(4):467\u2013476","journal-title":"Ther Drug Monit"},{"issue":"1","key":"2526_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jac\/dkh511","volume":"55","author":"RG Masterton","year":"2005","unstructured":"Masterton RG, Kuti JL, Turner PJ, Nicolau DP (2005) The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe. J Antimicrob Chemother 55(1):71\u201377","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2526_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","volume":"13","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D (2010) Testing CSfAS. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 13(6):180\u2013195","journal-title":"Drug Resist Updat"},{"issue":"2","key":"2526_CR24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1128\/AAC.01372-12","volume":"57","author":"S Han","year":"2013","unstructured":"Han S, Kim J, Yim H, Hur J, Song W, Lee J, Jeon S, Hong T, Woo H, Yim DS (2013) Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection. Antimicrob Agents Chemother 57(2):1006\u20131011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2526_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1365-2710.2011.01297.x","volume":"37","author":"T Aoyama","year":"2012","unstructured":"Aoyama T, Hirata K, Hirata R, Yamazaki H, Yamamoto Y, Hayashi H, Matsumoto Y (2012) Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients. J Clin Pharm Ther 37(3):356\u2013363","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"2526_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1365-2125.1996.03085.x","volume":"41","author":"AJ McLachlan","year":"1996","unstructured":"McLachlan AJ, Tett SE (1996) Pharmacokinetics of fluconazole in people with HIV infection: a population analysis. Br J Clin Pharmacol 41(4):291\u2013298","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"2526_CR27","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1128\/AAC.39.8.1835","volume":"39","author":"S Tett","year":"1995","unstructured":"Tett S, Moore S, Ray J (1995) Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection. Antimicrob Agents Chemother 39(8):1835\u20131841","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2526_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/00003088-199324010-00002","volume":"24","author":"D Debruyne","year":"1993","unstructured":"Debruyne D, Ryckelynck JP (1993) Clinical pharmacokinetics of fluconazole. Clin Pharmacokinet 24(1):10\u201327","journal-title":"Clin Pharmacokinet"},{"key":"2526_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","volume":"77","author":"SI Blot","year":"2014","unstructured":"Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev 77:3\u201311","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl 5","key":"2526_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1365-2036.16.s5.3.x","volume":"16","author":"JH Henriksen","year":"2002","unstructured":"Henriksen JH, Kiszka-Kanowitz M, Bendtsen F (2002) Review article: volume expansion in patients with cirrhosis. Aliment Pharmacol Ther 16(Suppl 5):12\u201323","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2526_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/lt.20017","volume":"10","author":"TA Gonwa","year":"2004","unstructured":"Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB (2004) Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 10(2):301\u2013309","journal-title":"Liver Transpl"},{"issue":"3","key":"2526_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/01.tp.0000228888.31242.2b","volume":"82","author":"M Cantarovich","year":"2006","unstructured":"Cantarovich M, Yoshida EM, Peltekian KM, Marotta PJ, Greig PD, Kneteman NM, Marleau D, Barkun J (2006) Poor prediction of the glomerular filtration rate using current formulas in de novo liver transplant patients. Transplantation 82(3):433\u2013436","journal-title":"Transplantation"},{"issue":"6","key":"2526_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1365-2125.2001.01390.x","volume":"51","author":"AS Gross","year":"2001","unstructured":"Gross AS, McLachlan AJ, Minns I, Beal JB, Tett SE (2001) Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. Br J Clin Pharmacol 51(6):547\u2013555","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"2526_CR34","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00228-014-1733-7","volume":"70","author":"TL Putt","year":"2014","unstructured":"Putt TL, Duffull SB, Schollum JB, Walker RJ (2014) GFR may not accurately predict aspects of proximal tubule drug handling. Eur J Clin Pharmacol 70(10):1221\u20131226","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2526_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481\u2013508","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2526_CR36","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1128\/AAC.47.4.1179-1186.2003","volume":"47","author":"D Andes","year":"2003","unstructured":"Andes D (2003) In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob Agents Chemother 47(4):1179\u20131186","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2526_CR37","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jac\/dkt508","volume":"69","author":"HR Ashbee","year":"2014","unstructured":"Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW (2014) Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother 69(5):1162\u20131176","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2526_CR38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cmi.2016.05.008","volume":"22","author":"LE Lopez-Cortes","year":"2016","unstructured":"Lopez-Cortes LE, Almirante B, Cuenca-Estrella M, Garnacho-Montero J, Padilla B, Puig-Asensio M et al (2016) Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort. Clin Microbiol Infect 22(8):733\u2013e1\u20138","journal-title":"Clin Microbiol Infect"},{"issue":"24","key":"2526_CR39","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1056\/NEJMoa066906","volume":"356","author":"AC Reboli","year":"2007","unstructured":"Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts R, Wible M, Goldstein BP, Schranz J, Krause DS, Walsh TJ, Anidulafungin Study Group (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356(24):2472\u20132482","journal-title":"N Engl J Med"},{"issue":"4","key":"2526_CR40","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/jac\/dks482","volume":"68","author":"GA Eschenauer","year":"2013","unstructured":"Eschenauer GA, Carver PL, Lin SW, Klinker KP, Chen YC, Potoski BA, Shields RK, Clancy CJ, Nguyen MH, Lam SW (2013) Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study. J Antimicrob Chemother 68(4):922\u2013926","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2526_CR41","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/jac\/dku169","volume":"69","author":"F Pea","year":"2014","unstructured":"Pea F, Righi E, Cojutti P, Carnelutti A, Baccarani U, Soardo G, Bassetti M (2014) Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis. J Antimicrob Chemother 69(9):2585\u20132586","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2526_CR42","first-page":"149","volume":"16","author":"I Kyriakidis","year":"2017","unstructured":"Kyriakidis I, Tragiannidis A, Munchen S, Groll AH (2017) Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf 16(2):149\u2013165","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"2526_CR43","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1128\/AAC.01657-09","volume":"54","author":"JL Wang","year":"2010","unstructured":"Wang JL, Chang CH, Young-Xu Y, Chan KA (2010) Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. Antimicrob Agents Chemother 54(6):2409\u20132419","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2526_CR44","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/516975","volume":"25","author":"JA Bronstein","year":"1997","unstructured":"Bronstein JA, Gros P, Hernandez E, Larroque P, Molinie C (1997) Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity. Clin Infect Dis 25(5):1266\u20131267","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2526_CR45","first-page":"111","volume":"24","author":"C Wells","year":"1992","unstructured":"Wells C, Lever AM (1992) Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge. J Inf Secur 24(1):111\u2013112","journal-title":"J Inf Secur"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2526-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T19:25:27Z","timestamp":1563650727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2526-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,21]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2526-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,21]]},"assertion":[{"value":"20 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}